Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-10-20

The coming of age for polycystic kidney disease.

Uyen A Tran, Oliver Wessely

Department of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland Clinic Foundation, Cleveland, Ohio, USA.Department of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland Clinic Foundation, Cleveland, Ohio, USA. · pubmed

Abstract

Autosomal dominant polycystic kidney disease leads to cyst formation and interstitial fibrosis in the kidney, with limited therapeutic options. A recent study demonstrates that polycystic kidney disease is characterized by the presence of senescence in the affected epithelial cells. This autosomal dominant polycystic kidney disease-associated senescence establishes a new perspective on disease progression and the paracrine impact of cystic epithelial cells. Most importantly, the senescence-associated secretory phenotype present in cystic kidney epithelial cells provides a novel therapeutic angle.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that senescence in cystic kidney epithelial cells contributes to disease progression in polycystic kidney disease and offers a new therapeutic angle. This research is relevant as it addresses cellular senescence, a key factor in aging and age-related diseases, potentially leading to novel interventions that target the underlying mechanisms of aging.

Author of this paper? Send a correction.